Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03126916 |
|---|---|
| Brief Title: | Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma |
| First Submitted : | April 17, 2017 |
| First Submitted that Met QC Criteria : | April 24, 2017 |
| First Posted : | April 25, 2017 |
| Last Update Submitted that Met QC Criteria : | February 3, 2021 |
| Last Update Posted : | February 4, 2021 |